Advertised as the most well-known telemedicine brand, we had a psychologist try Teladoc’s online therapy service for one ...

While clinical gene therapy celebrates its first successes, with several products already approved for clinical use and several hundreds in the final stages of the clinical approval pipeline, there is ...

uniQure (QURE) is back on traders’ radar after a sharp 9% one day decline, prompting fresh attention on how its gene therapy pipeline and current financial profile might line up with recent share ...

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment advancing across multiple sites Reached written alignment with FDA on inclusion ...